Aptamer Hot-Start Inhibition for Thermostable Polymerases
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nucleic acid synthesis assays using thermostable polymerases face issues with mispriming and non-specific product generation due to primer hybridization at lower temperatures, which can deplete reaction mixtures and mask target products.
Innovation Solution
Development of aptamers that form a secondary structure to reversibly inhibit thermostable polymerases at lower temperatures, dissociating at optimal reaction temperatures to allow primer extension and target product generation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the reaction mixture is maintained at lower or ambient temperature during assay preparation, then the thermostable polymerase remains stable and active, but mispriming and non-specific product generation occur due to premature primer hybridization
Solution Approach 1:
An aptamer is introduced as an intermediary molecule that binds to the thermostable polymerase at lower temperatures, blocking its active site and preventing it from interacting with primers. This mediator allows the polymerase to remain in the reaction mixture at ambient temperature without causing mispriming, and the inhibition is reversed when the temperature is raised to optimal polymerase activity levels
Solution Approach 2:
The invention utilizes temperature as a critical parameter to control polymerase activity. By changing the temperature from ambient (where the aptamer inhibits the polymerase) to optimal polymerase temperature (where the aptamer dissociates), the system transitions from an inhibited to an active state, enabling controlled primer extension only when desired
2Ease of operation
If the reaction is initiated at ambient temperature to allow component mixing, then ease of operation is improved, but primer dimers and non-target hybridization deplete reagents and mask target products
Solution Approach 1:
The aptamer is pre-bound to the thermostable polymerase during reaction mixture preparation at ambient temperature, creating a pre-assembled inhibited complex. This preliminary action allows all components to be mixed at convenient temperatures while the polymerase remains inactive, preventing premature primer binding. The inhibition is then reversed by a simple temperature increase to initiate specific amplification
3Reliability
If chemical inactivation methods are used to inhibit polymerase at ambient temperature, then hot start is achieved, but the inactivation chemistry may interfere with subsequent reaction components or reduce polymerase activity upon activation
Solution Approach 1:
The invention replaces chemical inactivation methods with a physical mechanism-based inhibition system. Instead of using chemical modifiers that covalently alter the polymerase, an aptamer uses reversible non-covalent interactions (hydrogen bonding, stacking interactions) to block the active site. This physical mechanism can be cleanly reversed by temperature increase, allowing full recovery of polymerase activity without chemical interference
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances the specificity and sensitivity of nucleic acid synthesis by reducing non-specific products and improving primer extension efficiency.
Implementation Method 1
The nucleic acid inhibitors can adapt a secondary structure to reversibly inhibit thermostable polymerases
Implementation Method 2
Upon increasing the temperature of the polymerase reaction mix to temperatures approximating the optimal reaction temperature of the thermostable polymerase, the inhibitory activity is removed
Data Source
AI summary
The present disclosure relates to aptamers for temperature-dependent reversible inhibition of thermostable polymerase activity in order to improve sensitivity and specificity of various reactions and assays involving hot start polynucleotide synthesis. Methods for use of the aptamers and related compositions and kits are also provided.